← Back to latest intelligence

Drugmakers to hand back €500m in rebates to Bulgaria’s health budget [Partner Content]

Editorial abstract

The Bulgarian pharmaceutical industry is calling for a 14% funding increase in 2027, warning that the current reimbursement model is becoming increasingly difficult to sustain

This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.

Story classification

Topics

Economic Policy · High confidence · AutomaticStory-text match

Public Health · High confidence · AutomaticStory-text match

War, Deterrence, and Regional Escalation · High confidence · AutomaticStory-text match

Regions

Europe · High confidence · AutomaticStory-text location match

Read original at Euractiv ↗